MCCC2 p.Gln393Pro
c.1178A>C · rs750782118 · VCV1407298
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9026 | likely pathogenic |
|---|---|---|
| REVEL | 0.952 | strongly pathogenic-leaning |
| SaProt | LLR -17.00 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 11 | GERP 1.6, phastCons 1 |
| Regional constraint | o/e 0.97 | unconstrained · MANE · 69 kb · p 0.42 · regional, not allelic |
| Overall | ||
| CADD | 28.2 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.00534% | 18,724 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,458 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- MCCC2
- Protein
- p.Gln393Pro
- Coding
- c.1178A>C
- MANE Select
- NM_022132
- dbSNP
- rs750782118
- Type
- single nucleotide variant
- Location
- chr5:71646239 (GRCh38)
- Gene constraint
- LOEUF 0.832 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 94.82 · 14 PDB
- Residue 393
- an α-helix; the coa carboxyltransferase c-terminal domain; the 'carboxyltransferase' region; a UniProt-annotated variant site (in mcc2d)
Disease context
3-methylcrotonyl-CoA carboxylase 2 deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor 3-methylcrotonyl-CoA carboxylase deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- All ages
- Prevalence
- 1-9 / 100 000 (Europe)
Similar variants
- MCCC2 p.Gln393= Likely benign ★ same residue
- MCCC2 c.1000-2A>G Likely pathogenic ★★ same condition
- MCCC2 c.1072+1G>A Likely pathogenic ★★ same condition
- MCCC2 c.1149+1G>A Pathogenic/Likely pathogenic ★★ same condition
- MCCC2 c.1149+1G>T Pathogenic/Likely pathogenic ★★ same condition
- MCCC2 c.1216+1G>A Likely pathogenic ★★ same condition
- MCCC2 c.1216+2T>A Pathogenic/Likely pathogenic ★★ same condition
- MCCC2 c.1216+2T>C Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mccc2-p-gln393pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown